$IMLFF SEATTLE, WA--(Marketwired - Jan 10, 2017) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing InMed Pharmaceuticals Inc. ( OTCQB : IMLFF ) ( CSE : IN ), a pre-clinical biopharmaceutical firm developing novel cannabinoid therapies. The company's CEO, Eric A. Adams, was recently featured in an interview on BNN, talking about the cannabis plant's enormous potential for new therapies in the pharmaceutical industry and highlighting the company's R&D pipeline targeting serious medical conditions like Epidermolysis Bullosa (EB) and Glaucoma.